Synta Pharmaceuticals News
Most Popular Synta Pharmaceuticals Story
Synta halts "stunningly disappointing" melanoma trial
In a devastating blow to the company, Synta Pharmaceuticals has halted a Phase III melanoma drug trial after a greater number of people taking elesclomol died than those receiving standard care. The Read more...
Latest Headlines
- October 5, 2009
- March 13, 2009
- February 27, 2009
- February 2, 2009
- January 5, 2009
- January 2, 2009
- December 12, 2008
- October 14, 2008
- November 13, 2007
- October 10, 2007
- September 27, 2007
- July 20, 2007
- November 21, 2006
- November 14, 2006
- September 14, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
